Skip to main content

Company

Pfizer Inc

NYSE:PFE

Pfizer Inc is a research-based biopharmaceutical company. The company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1.

293 stories · page 2 of 15

Pharma & Biotech

Pfizer data points to strong efficacy, particularly most at-risk groups

By Proactive 12/08/2024

Pharma & Biotech

Pfizer upgrades guidance; on track to deliver $4bn of net cost savings

By Proactive 30/07/2024

Pharma & Biotech

Pfizer's experimental gene therapy for haemophilia A shows promise in Phase 3 study

By Proactive 26/07/2024

Pharma & Biotech

Pfizer revenues drop due to lower COVID-related product demand

By Proactive 01/05/2024

Financial Services

Pfizer to sell down stake in Haleon

By Proactive 18/03/2024

Pharma & Biotech

Pfizer might get Alzheimer's lift from Viagra, study suggests

By Proactive 08/02/2024

Pharma & Biotech

Pfizer's earnings beat fails to mask longer-term challenges

By Proactive 30/01/2024

Pharma & Biotech

Pfizer guides for US$61.5bn sales from Covid-19, Paxlovid, Seagen

By Proactive 13/12/2023

Pharma & Biotech

Pfizer falls on weaker than expected 2024 revenue forecast

By Proactive 13/12/2023

Pharma & Biotech

Pfizer to close Seagen acquisition after donating cancer drug rights

By Proactive 12/12/2023

Pharma & Biotech

Biden admin announces framework to potentially seize drug patents to cut consumer costs

By Proactive 07/12/2023

Pharma & Biotech

Pfizer shares plunge after setbacks in obesity drug trial

By Proactive 01/12/2023

Pharma & Biotech

Pfizer to halve UK workforce at Discovery Park

By Proactive 15/11/2023

Pharma & Biotech

Pfizer Q3 earnings beat does little for battered share price

By Proactive 31/10/2023

Pharma & Biotech

Pfizer’s combination flu and COVID vaccine candidates effective, trial data shows

By Proactive 26/10/2023

Pharma & Biotech

Pfizer hopes to avoid scaring investors when it reports 3Q results on Halloween

By Proactive 23/10/2023

The Premarket: Hess, Chevron, Textainer, Roche, Pfizer, TotalEnergies and Bitcoin

By Proactive 23/10/2023

Pharma & Biotech

Roche pays US$7.1bn to buy irritable bowel drug developer

By Proactive 23/10/2023

Pharma & Biotech

Pfizer more than doubles price of Covid vaccine

Paxlovid has been supplied free to patients since the onset of the pandemic

By Proactive 19/10/2023

Pharma & Biotech

Impact Biomedical mulling IPO

By Proactive 18/10/2023